The Cooper Companies Overview

  • Year Founded
  • 1958

Year Founded

  • Status
  • Public

  • Employees
  • 16,000

Employees

  • Stock Symbol
  • COO

Stock Symbol

  • Investments
  • 13

  • Share Price
  • $80.84
  • (As of Wednesday Closing)

The Cooper Companies General Information

Description

CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.

Contact Information

Formerly Known As
Cooper Laboratories
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 6101 Bollinger Canyon Road
  • Suite 500
  • San Ramon, CA 94583
  • United States
+1 (925)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Corporate Office
  • 6101 Bollinger Canyon Road
  • Suite 500
  • San Ramon, CA 94583
  • United States
+1 (925)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

The Cooper Companies Stock Performance

As of 23-Apr-2025, The Cooper Companies’s stock price is $80.84. Its current market cap is $16.2B with 200M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$80.84 $79.79 $69.81 - $112.38 $16.2B 200M 2.02M $2.09

The Cooper Companies Financials Summary

As of 31-Jan-2025, The Cooper Companies has a trailing 12-month revenue of $3.93B.

In Thousands,
USD
TTM 31-Jan-2025 FY 2024 31-Oct-2024 FY 2023 31-Oct-2023 FY 2022 31-Oct-2022
EV 21,746,003 23,370,509 17,916,353 16,377,599
Revenue 3,928,500 3,895,400 3,593,200 3,308,400
EBITDA 1,095,300 1,071,700 885,900 878,700
Net Income 415,400 392,300 294,200 385,800
Total Assets 12,222,200 12,315,200 11,658,900 11,492,300
Total Debt 2,539,900 2,583,700 2,569,200 2,763,400
Public Fundamental Data provided by Morningstar, Inc. disclaimer

The Cooper Companies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore The Cooper Companies‘s full profile, request access.

Request a free trial

The Cooper Companies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperS
Therapeutic Devices
San Ramon, CA
16,000 As of 2024

San Clemente, CA
 

Audubon, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

The Cooper Companies Competitors (13)

One of The Cooper Companies’s 13 competitors is ICU Medical, a Corporation company based in San Clemente, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ICU Medical Corporation San Clemente, CA
Globus Medical Formerly VC-backed Audubon, PA
Hoya Group Corporation Tokyo, Japan
Philips Corporation Amsterdam, Netherlands
Boston Scientific Corporation Marlborough, MA
You’re viewing 5 of 13 competitors. Get the full list »

The Cooper Companies Patents

The Cooper Companies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170231659-A1 Embryo transfer catheters Inactive 13-Feb-2016
US-20160302828-A1 Syringe assemblies Active 29-Nov-2013
US-10617445-B2 Syringe assemblies Active 29-Nov-2013
US-9907572-B2 Syringe assemblies Active 29-Nov-2013
US-20180146985-A1 Syringe assemblies Active 29-Nov-2013 A61B17/435
To view The Cooper Companies’s complete patent history, request access »

The Cooper Companies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

The Cooper Companies Investments & Acquisitions (13)

The Cooper Companies’s most recent deal was a Merger/Acquisition with OBP Medical for . The deal was made on 03-May-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OBP Medical 03-May-2021 Merger/Acquisition Medical Supplies
SightGlass Vision 01-Jan-2021 Merger/Acquisition Therapeutic Devices
WaveShift (Therapeutic Devices) 01-Jan-2021 Merger/Acquisition Therapeutic Devices
SightGlass Vision 01-Jan-2020 Corporate Therapeutic Devices
Soflex Contact Lenses 06-Sep-2016 Merger/Acquisition Accessories
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

The Cooper Companies ESG

Risk Overview

Risk Rating

Updated March, 11, 2025

14.77 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,109

Rank

Percentile

Healthcare

Industry

of 587

Rank

Percentile

Medical Supplies

Subindustry

of 58

Rank

Percentile

To view The Cooper Companies’s complete esg history, request access »

The Cooper Companies Exits (1)

The Cooper Companies’s most recent exit was on 01-Jun-1992 from Hospital Group of America. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Hospital Group of America 01-Jun-1992 Completed
To view The Cooper Companies’s complete exits history, request access »

The Cooper Companies Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
WaveShift (Therapeutic Devices) Palo Alto, CA 2015
CooperSurgical Trumbull, CT 1990
Coopervision Manufacturing Puerto Rico Juana Diaz, PR 1985
Generate Life Sciences Los Angeles, CA 1977
CooperVision Victor, NY 1958

The Cooper Companies FAQs

  • When was The Cooper Companies founded?

    The Cooper Companies was founded in 1958.

  • Where is The Cooper Companies headquartered?

    The Cooper Companies is headquartered in San Ramon, CA.

  • What is the size of The Cooper Companies?

    The Cooper Companies has 16,000 total employees.

  • What industry is The Cooper Companies in?

    The Cooper Companies’s primary industry is Therapeutic Devices.

  • Is The Cooper Companies a private or public company?

    The Cooper Companies is a Public company.

  • What is The Cooper Companies’s stock symbol?

    The ticker symbol for The Cooper Companies is COO.

  • What is the current stock price of The Cooper Companies?

    As of 23-Apr-2025 the stock price of The Cooper Companies is $80.84.

  • What is the current market cap of The Cooper Companies?

    The current market capitalization of The Cooper Companies is $16.2B.

  • What is The Cooper Companies’s current revenue?

    The trailing twelve month revenue for The Cooper Companies is $3.93B.

  • Who are The Cooper Companies’s competitors?

    ICU Medical, Globus Medical, Hoya Group, Philips, and Boston Scientific are some of the 13 competitors of The Cooper Companies.

  • What is The Cooper Companies’s annual earnings per share (EPS)?

    The Cooper Companies’s EPS for 12 months was $2.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »